My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 510

    1.

    Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

    Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU; Infliximab-GCA Study Group.

    Ann Intern Med. 2007 May 1;146(9):621-30.PMID: 17470830 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial.

    Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG.

    Ann Intern Med. 2007 May 1;146(9):631-9.PMID: 17470831 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.

    Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Colombel JF, Panaccione R, D'Haens G, Li J, Rosenfeld MR, Kent JD, Pollack PF.

    Ann Intern Med. 2007 Jun 19;146(12):829-38. Epub 2007 Apr 30.PMID: 17470824 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. Adding infliximab to the treatment regimen for giant cell arteritis.

    [No authors listed]

    Ann Intern Med. 2007 May 1;146(9):I12. No abstract available. PMID: 17470826 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.

    Jover JA, Hernández-García C, Morado IC, Vargas E, Bañares A, Fernández-Gutiérrez B.

    Ann Intern Med. 2001 Jan 16;134(2):106-14.PMID: 11177313 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.

    Behm BW, Bickston SJ.

    Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893. Review.PMID: 18254120 [PubMed - indexed for MEDLINE]Related articles

    7.

    A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).

    Spiera RF, Mitnick HJ, Kupersmith M, Richmond M, Spiera H, Peterson MG, Paget SA.

    Clin Exp Rheumatol. 2001 Sep-Oct;19(5):495-501.PMID: 11579707 [PubMed - indexed for MEDLINE]Related articles

    8.

    Maintenance therapy with certolizumab pegol for Crohn's disease.

    Schreiber S, Khaliq-Kareemi M, Lawrance IC, Thomsen OØ, Hanauer SB, McColm J, Bloomfield R, Sandborn WJ; PRECISE 2 Study Investigators.

    N Engl J Med. 2007 Jul 19;357(3):239-50. Erratum in: N Engl J Med. 2007 Sep 27;357(13):1357. PMID: 17634459 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial.

    Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT; Anti-TNF Therapy Against Congestive Heart Failure Investigators.

    Circulation. 2003 Jul 1;107(25):3133-40. Epub 2003 Jun 9.PMID: 12796126 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Infliximab maintenance therapy for fistulizing Crohn's disease.

    Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ.

    N Engl J Med. 2004 Feb 26;350(9):876-85.PMID: 14985485 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.

    Mazlumzadeh M, Hunder GG, Easley KA, Calamia KT, Matteson EL, Griffing WL, Younge BR, Weyand CM, Goronzy JJ.

    Arthritis Rheum. 2006 Oct;54(10):3310-8.PMID: 17009270 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Infliximab for induction and maintenance therapy for ulcerative colitis.

    Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF.

    N Engl J Med. 2005 Dec 8;353(23):2462-76. Erratum in: N Engl J Med. 2006 May 18;354(20):2200. PMID: 16339095 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.

    Lawson MM, Thomas AG, Akobeng AK.

    Cochrane Database Syst Rev. 2006 Jul 19;3:CD005112. Review.PMID: 16856078 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.

    Caporali R, Cimmino MA, Ferraccioli G, Gerli R, Klersy C, Salvarani C, Montecucco C; Systemic Vasculitis Study Group of the Italian Society for Rheumatology.

    Ann Intern Med. 2004 Oct 5;141(7):493-500.PMID: 15466766 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects.

    Martínez-Taboada VM, Rodríguez-Valverde V, Carreño L, López-Longo J, Figueroa M, Belzunegui J, Mola EM, Bonilla G.

    Ann Rheum Dis. 2008 May;67(5):625-30. Epub 2007 Dec 17.PMID: 18086726 [PubMed - indexed for MEDLINE]Related articles

    16.

    Certolizumab pegol for the treatment of Crohn's disease.

    Sandborn WJ, Feagan BG, Stoinov S, Honiball PJ, Rutgeerts P, Mason D, Bloomfield R, Schreiber S; PRECISE 1 Study Investigators.

    N Engl J Med. 2007 Jul 19;357(3):228-38.PMID: 17634458 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Infliximab treatment for ocular and extraocular manifestations of Behçet's disease.

    Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.

    Jpn J Ophthalmol. 2007 May-Jun;51(3):191-6. Epub 2007 Jun 7.PMID: 17554481 [PubMed - indexed for MEDLINE]Related articles

    18.

    Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

    Probert CS, Hearing SD, Schreiber S, Kühbacher T, Ghosh S, Arnott ID, Forbes A.

    Gut. 2003 Jul;52(7):998-1002.PMID: 12801957 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis.

    Hernández-Rodríguez J, García-Martínez A, Casademont J, Filella X, Esteban MJ, López-Soto A, Fernández-Solà J, Urbano-Márquez A, Grau JM, Cid MC.

    Arthritis Rheum. 2002 Feb;47(1):29-35.PMID: 11932875 [PubMed - indexed for MEDLINE]Related articles

    20.

    A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

    Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Merkel PA, Fortin P, Flynn JA, Locker GA, Easley KA, Schned E, Hunder GG, Sneller MC, Tuggle C, Swanson H, Hernández-Rodríguez J, Lopez-Soto A, Bork D, Hoffman DB, Kalunian K, Klashman D, Wilke WS, Scheetz RJ, Mandell BF, Fessler BJ, Kosmorsky G, Prayson R, Luqmani RA, Nuki G, McRorie E, Sherrer Y, Baca S, Walsh B, Ferland D, Soubrier M, Choi HK, Gross W, Segal AM, Ludivico C, Puechal X; International Network for the Study of Systemic Vasculitides.

    Arthritis Rheum. 2002 May;46(5):1309-18.PMID: 12115238 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity